Skip to main content
Top
Published in: Virology Journal 1/2014

Open Access 01-12-2014 | Research

Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I

Authors: Sonia Shah, Aikaterini Alexaki, Vanessa Pirrone, Satinder Dahiya, Michael R Nonnemacher, Brian Wigdahl

Published in: Virology Journal | Issue 1/2014

Login to get access

Abstract

Background

HIV-1 gene expression is driven by the long terminal repeat (LTR), which contains many binding sites shown to interact with an array of host and viral factors. Selective pressures within the host as well as the low fidelity of reverse transcriptase lead to changes in the relative prevalence of genetic variants within the HIV-1 genome, including the LTR, resulting in viral quasispecies that can be differentially regulated and can potentially establish niches within specific cell types and tissues.

Methods

Utilizing flow cytometry and electromobility shift assays, specific single-nucleotide sequence polymorphisms (SNPs) were shown to alter both the phenotype of LTR-driven transcription and reactivation. Additional studies also demonstrated differential loading of transcription factors to probes derived from the double-variant LTR as compared to probes from the wild type.

Results

This study has identified specific SNPs within CCAAT/enhancer binding protein (C/EBP) site I and Sp site III (3 T, C-to-T change at position 3, and 5 T, C-to-T change at position 5 of the binding site, respectively) that alter LTR-driven gene transcription and may alter the course of viral latency and reactivation. The HIV-1 LAI LTRs containing the SNPs of interest were coupled to a plasmid encoding green fluorescent protein (GFP), and polyclonal HIV-1 LTR-GFP stable cell lines utilizing bone marrow progenitor, T, and monocytic cell lines were constructed and utilized to explore the LTR phenotype associated with these genotypic changes.

Conclusions

Although the 3 T and 5 T SNPs have been shown to be low-affinity binding sites, the fact that they can still result in effective HIV-1 LTR-driven gene expression, particularly within the TF-1 cell line, has suggested that the low binding site affinities associated with the 3 T C/EBP site I and 5 T Sp site III are potentially compensated for by the interaction of nuclear factor-κB with its corresponding binding sites under selected physiological and cellular conditions. Additionally, tumor necrosis factor-α and Tat can enhance basal transcription of each SNP-specific HIV-1 LTR; however, differential regulation of the LTR is both SNP- and cell type-specific.
Appendix
Available only for authorised users
Literature
1.
go back to reference Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF: Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 2007, 5: 95-106. 10.1038/nrmicro1580PubMedCrossRef Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF: Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 2007, 5: 95-106. 10.1038/nrmicro1580PubMedCrossRef
3.
go back to reference Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373: 123-126. 10.1038/373123a0PubMedCrossRef Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373: 123-126. 10.1038/373123a0PubMedCrossRef
4.
go back to reference Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61: 213-222. 10.1016/0092-8674(90)90802-LPubMedCrossRef Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61: 213-222. 10.1016/0092-8674(90)90802-LPubMedCrossRef
5.
go back to reference McElrath MJ, Pruett JE, Cohn ZA: Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci U S A 1989, 86: 675-679. 10.1073/pnas.86.2.675PubMedPubMedCentralCrossRef McElrath MJ, Pruett JE, Cohn ZA: Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci U S A 1989, 86: 675-679. 10.1073/pnas.86.2.675PubMedPubMedCentralCrossRef
6.
go back to reference Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, Fauci AS: Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum Retroviruses 1996, 12: 759-767. 10.1089/aid.1996.12.759PubMedCrossRef Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, Fauci AS: Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum Retroviruses 1996, 12: 759-767. 10.1089/aid.1996.12.759PubMedCrossRef
7.
go back to reference Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M: Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 1992, 89: 6580-6584. 10.1073/pnas.89.14.6580PubMedPubMedCentralCrossRef Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M: Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 1992, 89: 6580-6584. 10.1073/pnas.89.14.6580PubMedPubMedCentralCrossRef
8.
go back to reference Folks TM, Justement J, Kinter A, Schnittman S, Orenstein J, Poli G, Fauci AS: Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol 1988, 140: 1117-1122.PubMed Folks TM, Justement J, Kinter A, Schnittman S, Orenstein J, Poli G, Fauci AS: Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol 1988, 140: 1117-1122.PubMed
9.
go back to reference O'Brien TR: HIV-2 transmission: implications for spread of HIV-1. JAMA 1994, 271: 903-904. 10.1001/jama.1994.03510360027021PubMedCrossRef O'Brien TR: HIV-2 transmission: implications for spread of HIV-1. JAMA 1994, 271: 903-904. 10.1001/jama.1994.03510360027021PubMedCrossRef
10.
go back to reference Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B: Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 2004, 279: 51545-51553. 10.1074/jbc.M408573200PubMedPubMedCentralCrossRef Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B: Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 2004, 279: 51545-51553. 10.1074/jbc.M408573200PubMedPubMedCentralCrossRef
11.
go back to reference Nicholson JK, Cross GD, Callaway CS, McDougal JS: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol 1986, 137: 323-329.PubMed Nicholson JK, Cross GD, Callaway CS, McDougal JS: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol 1986, 137: 323-329.PubMed
12.
go back to reference Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985, 313: 1493-1497. 10.1056/NEJM198512123132401PubMedCrossRef Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985, 313: 1493-1497. 10.1056/NEJM198512123132401PubMedCrossRef
13.
go back to reference Shah S, Nonnemacher MR, Pirrone V, Wigdahl B: Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. J Neuroimmune Pharmacol 2010, 5: 278-293. 10.1007/s11481-010-9207-xPubMedPubMedCentralCrossRef Shah S, Nonnemacher MR, Pirrone V, Wigdahl B: Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. J Neuroimmune Pharmacol 2010, 5: 278-293. 10.1007/s11481-010-9207-xPubMedPubMedCentralCrossRef
14.
go back to reference Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR: Breaking down the barrier: the effects of HIV-1 on the blood–brain barrier. Brain Res 2011, 1399: 96-115.PubMedPubMedCentralCrossRef Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR: Breaking down the barrier: the effects of HIV-1 on the blood–brain barrier. Brain Res 2011, 1399: 96-115.PubMedPubMedCentralCrossRef
15.
go back to reference Fischer-Smith T, Croul S, Adeniyi A, Rybicka K, Morgello S, Khalili K, Rappaport J: Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 2004, 164: 2089-2099. 10.1016/S0002-9440(10)63767-4PubMedPubMedCentralCrossRef Fischer-Smith T, Croul S, Adeniyi A, Rybicka K, Morgello S, Khalili K, Rappaport J: Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 2004, 164: 2089-2099. 10.1016/S0002-9440(10)63767-4PubMedPubMedCentralCrossRef
16.
go back to reference Glass JD, Fedor H, Wesselingh SL, McArthur JC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995, 38: 755-762. 10.1002/ana.410380510PubMedCrossRef Glass JD, Fedor H, Wesselingh SL, McArthur JC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995, 38: 755-762. 10.1002/ana.410380510PubMedCrossRef
17.
go back to reference Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267: 483-489. 10.1126/science.7824947PubMedCrossRef Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267: 483-489. 10.1126/science.7824947PubMedCrossRef
18.
go back to reference Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, Sharp PM: The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996, 70: 7013-7029.PubMedPubMedCentral Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, Sharp PM: The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996, 70: 7013-7029.PubMedPubMedCentral
19.
go back to reference Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, Wigdahl B: Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. Journal of neurovirology 2011, 17: 92-109. 10.1007/s13365-010-0014-1PubMedPubMedCentralCrossRef Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, Wigdahl B: Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. Journal of neurovirology 2011, 17: 92-109. 10.1007/s13365-010-0014-1PubMedPubMedCentralCrossRef
20.
go back to reference Berkhout B, Jeang KT: Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1992, 66: 139-149.PubMedPubMedCentral Berkhout B, Jeang KT: Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1992, 66: 139-149.PubMedPubMedCentral
21.
go back to reference Quinones-Mateu ME, Mas A: Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E: LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 1998, 57: 11-20. 10.1016/S0168-1702(98)00082-3PubMedCrossRef Quinones-Mateu ME, Mas A: Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E: LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 1998, 57: 11-20. 10.1016/S0168-1702(98)00082-3PubMedCrossRef
22.
go back to reference Zhang S, Pointer D, Singer G, Feng Y, Park K, Zhao LJ: Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene 1998, 212: 157-166. 10.1016/S0378-1119(98)00178-4PubMedCrossRef Zhang S, Pointer D, Singer G, Feng Y, Park K, Zhao LJ: Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene 1998, 212: 157-166. 10.1016/S0378-1119(98)00178-4PubMedCrossRef
23.
go back to reference Nonnemacher MR, Irish BP, Liu Y, Mauger D, Wigdahl B: Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression. J Neuroimmunol 2004, 157: 39-47. 10.1016/j.jneuroim.2004.08.021PubMedCrossRef Nonnemacher MR, Irish BP, Liu Y, Mauger D, Wigdahl B: Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression. J Neuroimmunol 2004, 157: 39-47. 10.1016/j.jneuroim.2004.08.021PubMedCrossRef
24.
go back to reference Burdo TH, Gartner S, Mauger D, Wigdahl B: Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 2004,10(Suppl 1):7-14.PubMedCrossRef Burdo TH, Gartner S, Mauger D, Wigdahl B: Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 2004,10(Suppl 1):7-14.PubMedCrossRef
25.
go back to reference Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, Gartner S, Wigdahl B: High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol 2004, 23: 261-269. 10.1089/104454904773819842PubMedCrossRef Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, Gartner S, Wigdahl B: High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol 2004, 23: 261-269. 10.1089/104454904773819842PubMedCrossRef
26.
go back to reference Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B: HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol 2001, 7: 235-249. 10.1080/13550280152403281PubMedCrossRef Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B: HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol 2001, 7: 235-249. 10.1080/13550280152403281PubMedCrossRef
27.
go back to reference Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B: Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. J Virol 2001, 75: 1842-1856. 10.1128/JVI.75.4.1842-1856.2001PubMedPubMedCentralCrossRef Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B: Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. J Virol 2001, 75: 1842-1856. 10.1128/JVI.75.4.1842-1856.2001PubMedPubMedCentralCrossRef
28.
go back to reference Carter CC, Onafuwa-Nuga A, McNamara LA: Riddell Jt, Bixby D, Savona MR, Collins KL: HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010, 16: 446-451. 10.1038/nm.2109PubMedPubMedCentralCrossRef Carter CC, Onafuwa-Nuga A, McNamara LA: Riddell Jt, Bixby D, Savona MR, Collins KL: HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010, 16: 446-451. 10.1038/nm.2109PubMedPubMedCentralCrossRef
29.
go back to reference Burnett JC, Miller-Jensen K, Shah PS, Arkin AP, Schaffer DV: Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog 2009, 5: e1000260. 10.1371/journal.ppat.1000260PubMedPubMedCentralCrossRef Burnett JC, Miller-Jensen K, Shah PS, Arkin AP, Schaffer DV: Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog 2009, 5: e1000260. 10.1371/journal.ppat.1000260PubMedPubMedCentralCrossRef
30.
go back to reference Jordan A, Defechereux P, Verdin E: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 2001, 20: 1726-1738. 10.1093/emboj/20.7.1726PubMedPubMedCentralCrossRef Jordan A, Defechereux P, Verdin E: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 2001, 20: 1726-1738. 10.1093/emboj/20.7.1726PubMedPubMedCentralCrossRef
31.
go back to reference Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD: Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004, 2: E234. 10.1371/journal.pbio.0020234PubMedPubMedCentralCrossRef Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD: Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004, 2: E234. 10.1371/journal.pbio.0020234PubMedPubMedCentralCrossRef
32.
go back to reference Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV: Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005, 122: 169-182. 10.1016/j.cell.2005.06.006PubMedCrossRef Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV: Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005, 122: 169-182. 10.1016/j.cell.2005.06.006PubMedCrossRef
33.
go back to reference Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F: HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002, 110: 521-529. 10.1016/S0092-8674(02)00864-4PubMedCrossRef Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F: HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002, 110: 521-529. 10.1016/S0092-8674(02)00864-4PubMedCrossRef
34.
go back to reference Koot M, Keet IP, Vos AH, De Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, Tersmette M: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118: 681-688. 10.7326/0003-4819-118-9-199305010-00004PubMedCrossRef Koot M, Keet IP, Vos AH, De Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, Tersmette M: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118: 681-688. 10.7326/0003-4819-118-9-199305010-00004PubMedCrossRef
35.
go back to reference Nielsen C, Pedersen C, Lundgren JD, Gerstoft J: Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993, 7: 1035-1040. 10.1097/00002030-199308000-00002PubMedCrossRef Nielsen C, Pedersen C, Lundgren JD, Gerstoft J: Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993, 7: 1035-1040. 10.1097/00002030-199308000-00002PubMedCrossRef
36.
go back to reference Corboy JR, Buzy JM, Zink MC, Clements JE: Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 1992, 258: 1804-1808. 10.1126/science.1465618PubMedCrossRef Corboy JR, Buzy JM, Zink MC, Clements JE: Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 1992, 258: 1804-1808. 10.1126/science.1465618PubMedCrossRef
37.
go back to reference Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B: Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 2003, 9: 55-68. 10.1080/13550280390173292PubMedCrossRef Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B: Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 2003, 9: 55-68. 10.1080/13550280390173292PubMedCrossRef
38.
go back to reference Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B: HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacothe 2003, 57: 41-48.CrossRef Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B: HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacothe 2003, 57: 41-48.CrossRef
39.
go back to reference McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B: Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 2000, 274: 262-277. 10.1006/viro.2000.0476PubMedCrossRef McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B: Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 2000, 274: 262-277. 10.1006/viro.2000.0476PubMedCrossRef
40.
go back to reference Berkhout B, Gatignol A, Rabson AB, Jeang KT: TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 1990, 62: 757-767. 10.1016/0092-8674(90)90120-4PubMedCrossRef Berkhout B, Gatignol A, Rabson AB, Jeang KT: TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 1990, 62: 757-767. 10.1016/0092-8674(90)90120-4PubMedCrossRef
41.
go back to reference Harrich D, Garcia J, Mitsuyasu R, Gaynor R: TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J 1990, 9: 4417-4423.PubMedPubMedCentral Harrich D, Garcia J, Mitsuyasu R, Gaynor R: TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J 1990, 9: 4417-4423.PubMedPubMedCentral
42.
go back to reference Gomez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcami J, Lopez-Cabrera M: The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J Biol Chem 2001, 276: 35435-35443. 10.1074/jbc.M103020200PubMedCrossRef Gomez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcami J, Lopez-Cabrera M: The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J Biol Chem 2001, 276: 35435-35443. 10.1074/jbc.M103020200PubMedCrossRef
43.
go back to reference Leonard J, Parrott C, Buckler-White AJ, Turner W, Ross EK, Martin MA, Rabson AB: The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 1989, 63: 4919-4924.PubMedPubMedCentral Leonard J, Parrott C, Buckler-White AJ, Turner W, Ross EK, Martin MA, Rabson AB: The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 1989, 63: 4919-4924.PubMedPubMedCentral
44.
go back to reference Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA: Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 1991, 65: 4350-4358.PubMedPubMedCentral Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA: Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 1991, 65: 4350-4358.PubMedPubMedCentral
45.
go back to reference Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B: Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009, 6: 118. 10.1186/1742-4690-6-118PubMedPubMedCentralCrossRef Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B: Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009, 6: 118. 10.1186/1742-4690-6-118PubMedPubMedCentralCrossRef
46.
go back to reference Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85: 1135-1148. 10.1016/S0092-8674(00)81313-6PubMedCrossRef Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85: 1135-1148. 10.1016/S0092-8674(00)81313-6PubMedCrossRef
47.
go back to reference Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992, 66: 3183-3187.PubMedPubMedCentral Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992, 66: 3183-3187.PubMedPubMedCentral
48.
go back to reference Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261: 1179-1181. 10.1126/science.8356453PubMedCrossRef Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261: 1179-1181. 10.1126/science.8356453PubMedCrossRef
49.
go back to reference Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 1989, 86: 7611-7615. 10.1073/pnas.86.19.7611PubMedPubMedCentralCrossRef Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 1989, 86: 7611-7615. 10.1073/pnas.86.19.7611PubMedPubMedCentralCrossRef
50.
go back to reference Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T: Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Ciba Found Symp 1992, 167: 47-62. discussion 62–47PubMed Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T: Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Ciba Found Symp 1992, 167: 47-62. discussion 62–47PubMed
51.
go back to reference LeClair KP, Blanar MA, Sharp PA: The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 1992, 89: 8145-8149. 10.1073/pnas.89.17.8145PubMedPubMedCentralCrossRef LeClair KP, Blanar MA, Sharp PA: The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 1992, 89: 8145-8149. 10.1073/pnas.89.17.8145PubMedPubMedCentralCrossRef
52.
go back to reference Henderson AJ, Zou X, Calame KL: C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995, 69: 5337-5344.PubMedPubMedCentral Henderson AJ, Zou X, Calame KL: C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995, 69: 5337-5344.PubMedPubMedCentral
53.
go back to reference Connor RI, Mohri H, Cao Y, Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993, 67: 1772-1777.PubMedPubMedCentral Connor RI, Mohri H, Cao Y, Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993, 67: 1772-1777.PubMedPubMedCentral
54.
go back to reference Parrott C, Seidner T, Duh E, Leonard J, Theodore TS, Buckler-White A, Martin MA, Rabson AB: Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes. J Virol 1991, 65: 1414-1419.PubMedPubMedCentral Parrott C, Seidner T, Duh E, Leonard J, Theodore TS, Buckler-White A, Martin MA, Rabson AB: Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes. J Virol 1991, 65: 1414-1419.PubMedPubMedCentral
55.
go back to reference Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR: Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol 1994, 68: 3163-3174.PubMedPubMedCentral Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR: Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol 1994, 68: 3163-3174.PubMedPubMedCentral
56.
go back to reference Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996, 70: 4053-4062.PubMedPubMedCentral Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996, 70: 4053-4062.PubMedPubMedCentral
57.
go back to reference Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers RC: Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 1997, 232: 319-331. 10.1006/viro.1997.8586PubMedCrossRef Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers RC: Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 1997, 232: 319-331. 10.1006/viro.1997.8586PubMedCrossRef
58.
go back to reference Neumann E, Riepl B, Knedla A, Lefevre S, Tarner IH, Grifka J, Steinmeyer J, Scholmerich J, Gay S, Muller-Ladner U: Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2010, 12: R83. 10.1186/ar3010PubMedPubMedCentralCrossRef Neumann E, Riepl B, Knedla A, Lefevre S, Tarner IH, Grifka J, Steinmeyer J, Scholmerich J, Gay S, Muller-Ladner U: Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2010, 12: R83. 10.1186/ar3010PubMedPubMedCentralCrossRef
59.
go back to reference Alexaki A, Quiterio SJ, Liu Y, Irish B, Kilareski E, Nonnemacher MR, Wigdahl B: PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcription. DNA Cell Biol 2007, 26: 387-394. 10.1089/dna.2006.0542PubMedCrossRef Alexaki A, Quiterio SJ, Liu Y, Irish B, Kilareski E, Nonnemacher MR, Wigdahl B: PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcription. DNA Cell Biol 2007, 26: 387-394. 10.1089/dna.2006.0542PubMedCrossRef
60.
go back to reference Krebs FC, Hogan TH, Quiterio S, Gartner S, Wigdahl B: Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. Los Alamos National Laboratory HIV Sequence: Compendium; 2002. Krebs FC, Hogan TH, Quiterio S, Gartner S, Wigdahl B: Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. Los Alamos National Laboratory HIV Sequence: Compendium; 2002.
61.
go back to reference Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11: 1475-1489. 10.1093/nar/11.5.1475PubMedPubMedCentralCrossRef Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11: 1475-1489. 10.1093/nar/11.5.1475PubMedPubMedCentralCrossRef
62.
go back to reference Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3PubMedCrossRef Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3PubMedCrossRef
Metadata
Title
Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I
Authors
Sonia Shah
Aikaterini Alexaki
Vanessa Pirrone
Satinder Dahiya
Michael R Nonnemacher
Brian Wigdahl
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2014
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-11-92

Other articles of this Issue 1/2014

Virology Journal 1/2014 Go to the issue